JCO Oncology Practice: Patient- and Provider-Level Factors Associated With Telehealth Utilization

JCO Oncology Practice: Patient- and Provider-Level Factors Associated With Telehealth Utilization

According to data published in JCO Oncology Practice, incorporation of telehealth visits during the pandemic did not result in redundant care as determined by per-physician patient volume. Results showed the telehealth utilization rate increased from less than 0.01 percent in 2019, prior to the start of the COVID-19 pandemic, to 11 percent in 2020. The findings suggest that telehealth can be integrated into cancer practices without evidence of duplicative care. Future work should examine sustainable reimbursement structures and policies to ensure accessibility of telehealth as a means to facilitate equitable, patient-centered cancer care. For additional coverage, see Healio.